London, Canada

Clinton Threlfall

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Clinton Threlfall

Introduction

Clinton Threlfall is a notable inventor based in London, Canada, recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Threlfall has focused his research on developing innovative treatments for HIV.

Latest Patents

Threlfall's latest patents include compounds and methods for the treatment of HIV. These inventions relate to specific compounds of Formulae I and/or II, which may include pharmaceutically-acceptable salts, hydrates, solvates, tautomers, optical isomers, E-isomers, Z-isomers, or combinations thereof. The compounds feature various substituents, including elements such as selenium, nitrogen, and oxygen, which are crucial for their therapeutic efficacy. The patents also detail methods of administration and the use of these compounds in treating HIV.

Career Highlights

Threlfall is currently associated with Critical Outcome Technologies Inc., where he continues to advance his research and development efforts. His work has been instrumental in exploring new avenues for HIV treatment, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Threlfall has collaborated with esteemed colleagues, including Wayne Danter and Sylvain Guizzetti. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Clinton Threlfall's contributions to the field of HIV treatment through his innovative patents highlight his dedication to advancing medical science. His work not only reflects his expertise but also his commitment to improving the lives of those affected by HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…